SCHADE CHRISTIAN S
SEC CIK 1214496 · EDGAR
BoughtSold
Most active insiders at IART, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GRAVES JEFFREY A | Dir | $102.2K | — |
| 2 | Veillon-Berteloot Chantal | EVP, CHRO | — | — |
| 3 | Knight Lea Daniels | EVP, CFO | — | — |
| 4 | Singh Harvinder | EVP, Pres, INTERNATIONAL | — | — |
| 5 | McBreen Michael J. | EVP, Pres, CSS | — | — |
| 6 | Poul Mojdeh | Pres, CEO, Dir | — | — |
| 7 | Mosebrook Jeffrey | SVP, Fin, Princ Acct Off | — | — |
| 8 | DAVIS ROBERT T. JR. | EVP, Pres, TT | — | — |
| 9 | HILL BARBARA B | Dir | — | — |
| 10 | BRADLEY KEITH | Dir | — | — |
SCHADE CHRISTIAN S made no open-market trades at IART in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-13 | 2025-05-09 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Dir | A - Grant | $0.00 | +26.5K | 90.0K | +42% | $0 |
| 2024-05-13 | 2024-05-09 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Dir | A - Grant | $0.00 | +8,696 | 63.5K | +16% | $0 | |
| 2023-05-16 | 2023-05-12 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Dir | A - Grant | $0.00 | +4,486 | 54.8K | +9% | $0 | |
| D | 2022-08-01 | 2022-07-28 | APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | Dir | A - Grant | $0.00 | +32.4K | 259.2K | +14% | $0 |
| 2022-06-07 | 2022-06-03 | APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | COB, CEO, Dir | F - Tax | $0.81 | -65.8K | 226.8K | -22% | -$53.3K | |
| 2022-05-19 | 2022-05-18 | APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | COB, CEO, Dir | P - Purchase | $0.64 | +37.5K | 292.6K | +15% | +$24.0K | |
| M | 2022-05-17 | 2022-05-13 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Dir | A - Grant | $0.00 | +4,721 | 46.9K | +11% | $0 |
| D | 2022-03-14 | 2022-03-10 | APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | COB, CEO, Dir | A - Grant | $0.00 | +100.1K | 255.1K | +65% | $0 |
| 2022-03-01 | 2022-02-25 | APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | COB, CEO, Dir | F - Tax | $1.74 | -21.6K | 155.0K | -12% | -$37.7K |
Purchase Sale Sale after option exercise All abbreviations